87 related articles for article (PubMed ID: 27923328)
1. Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.
Santoro M; Menegaz BA; Lamhamedi-Cherradi SE; Molina ER; Wu D; Priebe W; Ludwig JA; Mikos AG
Tissue Eng Part A; 2017 Jan; 23(1-2):80-89. PubMed ID: 27923328
[TBL] [Abstract][Full Text] [Related]
2. Tissue-Engineered Model of Human Osteolytic Bone Tumor.
Villasante A; Marturano-Kruik A; Robinson ST; Liu Z; Guo XE; Vunjak-Novakovic G
Tissue Eng Part C Methods; 2017 Feb; 23(2):98-107. PubMed ID: 28068876
[TBL] [Abstract][Full Text] [Related]
3. Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma.
Bailey KM; Airik M; Krook MA; Pedersen EA; Lawlor ER
Neoplasia; 2016 Aug; 18(8):480-8. PubMed ID: 27566104
[TBL] [Abstract][Full Text] [Related]
4. The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling.
Hawkins AG; Basrur V; da Veiga Leprevost F; Pedersen E; Sperring C; Nesvizhskii AI; Lawlor ER
Mol Cell Proteomics; 2018 May; 17(5):901-912. PubMed ID: 29386236
[TBL] [Abstract][Full Text] [Related]
5. Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach.
Asfa S; Toy HI; Arshinchi Bonab R; Chrousos GP; Pavlopoulou A; Geronikolou SA
Int J Environ Res Public Health; 2023 Jul; 20(13):. PubMed ID: 37444135
[TBL] [Abstract][Full Text] [Related]
6. Mimicking biophysical stimuli within bone tumor microenvironment.
Marturano-Kruik A; Yeager K; Bach D; Villasante A; Cimetta E; Vunjak-Novakovic G
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():3561-4. PubMed ID: 26737062
[TBL] [Abstract][Full Text] [Related]
7. Biomechanical Aspects in Bone Tumor Engineering.
Menshikh K; Banicevic I; Obradovic B; Rimondini L
Tissue Eng Part B Rev; 2024 Apr; 30(2):217-229. PubMed ID: 37830183
[TBL] [Abstract][Full Text] [Related]
8. Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma.
Bailey KM
Oncotarget; 2018 Dec; 9(99):37270-37271. PubMed ID: 30647860
[No Abstract] [Full Text] [Related]
9. Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities.
Radic-Sarikas B; Tsafou KP; Emdal KB; Papamarkou T; Huber KV; Mutz C; Toretsky JA; Bennett KL; Olsen JV; Brunak S; Kovar H; Superti-Furga G
Mol Cancer Ther; 2017 Jan; 16(1):88-101. PubMed ID: 28062706
[TBL] [Abstract][Full Text] [Related]
10. The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.
Schwentner R; Herrero-Martin D; Kauer MO; Mutz CN; Katschnig AM; Sienski G; Alonso J; Aryee DN; Kovar H
Oncotarget; 2017 Feb; 8(7):10980-10993. PubMed ID: 28030800
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of EWSR1/FLI1 expression alters the transcriptome of Ewing sarcoma cells in vitro.
Wang J; Jiang W; Yan Y; Chen C; Yu Y; Wang B; Zhao H
J Bone Oncol; 2016 Nov; 5(4):153-158. PubMed ID: 28008375
[TBL] [Abstract][Full Text] [Related]
12. 3D Tissue-Engineered Tumor Model for Ewing's Sarcoma That Incorporates Bone-like ECM and Mineralization.
Molina ER; Chim LK; Salazar MC; Koons GL; Menegaz BA; Ruiz-Velasco A; Lamhamedi-Cherradi SE; Vetter AM; Satish T; Cuglievan B; Smoak MM; Scott DW; Ludwig JA; Mikos AG
ACS Biomater Sci Eng; 2020 Jan; 6(1):539-552. PubMed ID: 33463239
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma.
Chim LK; Williams IL; Bashor CJ; Mikos AG
Biomaterials; 2023 May; 296():122076. PubMed ID: 36931102
[TBL] [Abstract][Full Text] [Related]
14. Comparative characteristics of small cell lung cancer and Ewing's sarcoma: a narrative review.
Hamilton G
Transl Lung Cancer Res; 2022 Jun; 11(6):1185-1198. PubMed ID: 35832443
[TBL] [Abstract][Full Text] [Related]
15. Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety.
Chramiec A; Teles D; Yeager K; Marturano-Kruik A; Pak J; Chen T; Hao L; Wang M; Lock R; Tavakol DN; Lee MB; Kim J; Ronaldson-Bouchard K; Vunjak-Novakovic G
Lab Chip; 2020 Nov; 20(23):4357-4372. PubMed ID: 32955072
[TBL] [Abstract][Full Text] [Related]
16. The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma.
Jin W
Front Cell Dev Biol; 2020; 8():613. PubMed ID: 32754598
[TBL] [Abstract][Full Text] [Related]
17. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
18. Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.
Molina ER; Chim LK; Barrios S; Ludwig JA; Mikos AG
Tissue Eng Part B Rev; 2020 Jun; 26(3):249-271. PubMed ID: 32057288
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
